AMELIORATING EFFECTS OF HISTIDINE ON SCOPOLAMINE-INDUCED LEARNING-DEFICITS USING AN ELEVATED PLUS-MAZE TEST IN MICE

被引:54
作者
MIYAZAKI, S
IMAIZUMI, M
ONODERA, K
机构
[1] YAMASA CORP,DIV RES & DEV,BIOL LAB,CHOSHI,CHIBA 288,JAPAN
[2] TOHOKU UNIV,SCH DENT,DEPT PHARMACOL,AOBA KU,SENDAI,MIYAGI 980,JAPAN
关键词
HISTIDINE; HISTAMINE; LEARNING; HISTAMINE H-1 RECEPTOR; ELEVATED PLUS-MAZE TEST; SCOPOLAMINE;
D O I
10.1016/0024-3205(95)00122-M
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We investigated the effects of histidine on scopolamine-induced learning deficits in the elevated plus-maze test in mice. In this test, transfer latency (TL), the time mice took to move from the open arm to the enclosed arm, was used as an index of learning and memory. Intraperitoneal administration of scopolamine (0.5 mg/kg) prolonged the TL on day 2 compared with that in the saline-treated group. Histidine loading (500, 800 and 1600 mg/kg) reversed the prolongation of the TL induced by scopolamine. This ameliorating effect of histidine was abolished by alpha-fluoromethylhistidine, an inhibitor of histidine decarboxylase, suggesting that histidine itself has no such ameliorating effect. Moreover, the ameliorating effect of histidine was antagonized by a histamine H-1 receptor antagonist, pyrilamine. However, zolantidine, a histamine H-2 receptor antagonist, showed no antagonism of the effect of histidine. Thus, histamine, a decarboxylated product of histidine, elicited an ameliorating effect on scopolamine-induced learning deficit via histamine H-1 receptors in mice. These findings clearly indicated that there is a close relationship between histaminergic and cholinergic systems in the brain, and that histamine may play certain important roles in learning and memory.
引用
收藏
页码:1563 / 1570
页数:8
相关论文
共 45 条
[1]  
Schwartz, Arrang, Garabarg, Pollard, Ruat, Physiol. Rev., 71, pp. 1-51, (1991)
[2]  
Wada, Inagaki, Yamatodani, Watanabe, Trends Neurosci., 14, pp. 415-419, (1991)
[3]  
Onodera, Yamatodani, Watanabe, Wada, Progress in Neurobiol., 42, pp. 685-702, (1994)
[4]  
Cacabelos, Meth. Find. Exp. Clin. Pharmacol., 12, pp. 341-376, (1990)
[5]  
Cacabelos, Histaminergic Neurons: Morphology and Function, pp. 241-270, (1991)
[6]  
Mochizuki, Yamatodani, Okakura, Horii, Inagaki, Wada, Physiol. Behav., 51, pp. 391-394, (1992)
[7]  
de Almeida, Equierdo, Arch. Int. Pharmacodyn., 283, pp. 193-198, (1986)
[8]  
de Almeida, Equierdo, Arch. Int. Pharmacodyn., 291, pp. 202-207, (1988)
[9]  
Kamei, Tasaka, Biol. Pharm. Bull., 16, pp. 128-132, (1993)
[10]  
Alvarez, Franco, Fernandez-Novoa, Cacabelos, Agents Actions, 38, pp. C263-C265, (1993)